Which aspects of stroke do animal models capture? A multitracer micro-PET study of focal ischemia with endothelin-1

Cerebrovascular Diseases

Volumn 41, Issue 3-4, 2016, Pages 139-147

  Schirrmacher, Ralf ^a,d   Dea, Melvin ^b   Heiss, Wolf Dieter ^e   Kostikov, Alexey ^a   Funck, Thomas ^c   Quessy, Stephan ^b   Bedell, Barry ^a,d   Dancause, Numa ^b   Thiel, Alexander ^c,d  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

Endothelin 1; Focal ischemia; Multitracer PET; Rat

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; ENDOTHELIN 1; FLUMAZENIL C 11; FLUMAZENIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN SIZE; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; EXPERIMENTAL STROKE; FOCAL ISCHEMIA; HEMISPHERE; MALE; NONHUMAN; PATHOPHYSIOLOGY; PERFUSION; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; RAT; TISSUE NECROSIS; ANIMAL; BRAIN; BRAIN CIRCULATION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DRUG EFFECTS; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIA; METABOLISM; MOTOR CORTEX; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; ENDOTHELIN-1; FLUMAZENIL; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIA; MALE; MODELS, ANIMAL; MOTOR CORTEX; RATS, SPRAGUE-DAWLEY; STROKE;

EID: 84954417430     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000442997     Document Type: Article

References (30)

1. Durukan A, Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 2007; 87: 179-197
2. Hossmann KA. Cerebral ischemia: models, methods and outcomes. Neuropharmacology 2008; 55: 257-270
3. Carmichael ST. Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx 2005; 2: 396-409
4. Hossmann KA. The two pathophysiologies of focal brain ischemia: implications for translational stroke research. J Cereb Blood Flow Metab 2012; 32: 1310-1316
5. Mergenthaler P, Meisel A. Do stroke models model stroke? Dis Model Mech 2012; 5: 718-725
6. Gharbawie OA, Gonzalez CL, Williams PT, Kleim JA, Whishaw IQ. Middle cerebral artery (MCA) stroke produces dysfunction in adjacent motor cortex as detected by intracortical microstimulation in rats. Neuroscience 2005; 130: 601-610
7. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415
8. Robinson MJ, Macrae IM, Todd M, Reid JL, McCulloch J. Reduction of local cerebral blood flow to pathological levels by endothelin-1 applied to the middle cerebral artery in the rat. Neurosci Lett 1990; 118: 269-272
9. Sharkey J, Ritchie IM, Kelly PA. Perivascular microapplication of endothelin-1: a new model of focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 1993; 13: 865-871
10. Biernaskie J, Corbett D, Peeling J, Wells J, Lei H. A serial MR study of cerebral blood flow changes and lesion development following endothelin-1-induced ischemia in rats. Magn Reson Med 2001; 46: 827-830
11. Nikolova S, Moyanova S, Hughes S, Bellyou-Camilleri M, Lee TY, Bartha R. Endothelin-1 induced MCAO: dose dependency of cerebral blood flow. J Neurosci Methods 2009; 179: 22-28
12. Fuxe K, Bjelke B, Andbjer B, Grahn H, Rimondini R, Agnati LF. Endothelin-1 induced lesions of the frontoparietal cortex of the rat. A possible model of focal cortical ischemia. Neuroreport 1997; 8: 2623-2629
13. Gilmour G, Iversen SD, O Neill MF, Bannerman DM. The effects of intracortical endothelin-1 injections on skilled forelimb use: implications for modelling recovery of function after stroke. Behav Brain Res 2004; 150: 171-183
14. Soleman S, Yip P, Leasure JL, Moon L. Sustained sensorimotor impairments after endothelin-1 induced focal cerebral ischemia (stroke) in aged rats. Exp Neurol 2010; 222: 13-24
15. Windle V, Szymanska A, Granter-Button S, White C, Buist R, Peeling J, Corbett D. An analysis of four different methods of producing focal cerebral ischemia with endothelin-1 in the rat. Exp Neurol 2006; 201: 324-334
16. Livingston-Thomas JM, Hume AW, Doucette TA, Tasker RA. A novel approach to induction and rehabilitation of deficits in forelimb function in a rat model of ischemic stroke. Acta Pharmacol Sin 2013; 34: 104-112
17. Mansoori BK, Jean-Charles L, Touvykine B, Liu A, Quessy S, Dancause N. Acute inactivation of the contralesional hemisphere for longer durations improves recovery after cortical injury. Exp Neurol 2014; 254: 18-28
18. Thiel A, Lottgen J, Grond M, Pietrzyk U, Heiss WD. Estimation of regional cerebral blood flow levels in ischemia using [(15)O] water of [(11)C]flumazenil PET without arterial input function. J Comput Assist Tomogr 2001; 25: 446-451
19. Heiss WD, Graf R, Fujita T, Ohta K, Bauer B, Lottgen J, Wienhard K. Early detection of irreversibly damaged ischemic tissue by flumazenil positron emission tomography in cats. Stroke 1997; 28: 2045-2051; discussion 2051-2052
20. Sette G, Baron JC, Young AR, Miyazawa H, Tillet I, Barre L, Travere JM, Derlon JM, MacKenzie ET. In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon. Stroke 1993; 24: 2046-2057; discussion 2057-2058
21. Heiss WD, Grond M, Thiel A, Ghaemi M, Sobesky J, Rudolf J, Bauer B, Wienhard K. Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke. Stroke 1998; 29: 454-461
22. Rojas S, Martin A, Pareto D, Herance JR, Abad S, Ruiz A, Flotats N, Gispert JD, Llop J, Gomez-Vallejo V, Planas AM. Positron emission tomography with 11C-flumazenil in the rat shows preservation of binding sites during the acute phase after 2 h-Transient focal ischemia. Neuroscience 2011; 182: 208-216
23. Read SJ, Hirano T, Abbott DF, Sachinidis JI, Tochon-Danguy HJ, Chan JG, Egan GF, Scott AM, Bladin CF, McKay WJ, Donnan GA. Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole. Neurology 1998; 51: 1617-1621
24. Markus R, Donnan G, Kazui S, Read S, Reutens D. Penumbral topography in human stroke: methodology and validation of the Penumbragram . Neuroimage 2004; 21: 1252-1259
25. Rojas S, Herance JR, Abad S, Jimenez X, Pareto D, Ruiz A, Torrent E, Figueiras FP, Popota F, Fernandez-Soriano FJ, Planas AM, Gispert JD. Evaluation of hypoxic tissue dynamics with 18F-FMISO PET in a rat model of permanent cerebral ischemia. Mol Imaging Biol 2011; 13: 558-564
26. Saita K, Chen M, Spratt NJ, Porritt MJ, Liberatore GT, Read SJ, Levi CR, Donnan GA, Ackermann U, Tochon-Danguy HJ, Sachinidis JI, Howells DW. Imaging the ischemic penumbra with 18F-fluoromisonidazole in a rat model of ischemic stroke. Stroke 2004; 35: 975-980
27. Takasawa M, Beech JS, Fryer TD, Jones PS, Ahmed T, Smith R, Aigbirhio FI, Baron JC. Single-subject statistical mapping of acute brain hypoxia in the rat following middle cerebral artery occlusion: a microPET study. Exp Neurol 2011; 229: 251-258
28. Alawneh JA, Moustafa RR, Marrapu ST, Jensen-Kondering U, Morris RS, Jones PS, Aigbirhio FI, Fryer TD, Carpenter TA, Warburton EA, Baron JC. Diffusion and perfusion correlates of the 18F-MISO PET lesion in acute stroke: pilot study. Eur J Nucl Med Mol Imaging 2014; 41: 736-744
29. Macrae IM, Robinson MJ, Graham DI, Reid JL, McCulloch J. Endothelin-1-induced reductions in cerebral blood flow: dose dependency, time course, and neuropathological consequences. J Cereb Blood Flow Metab 1993; 13: 276-284
30. Fukumoto D, Hosoya T, Nishiyama S, Harada N, Iwata H, Yamamoto S, Tsukada H. Multiparametric assessment of acute and subacute ischemic neuronal damage: a small animal positron emission tomography study with rat photochemically induced thrombosis model. Synapse 2011; 65: 207-214